Detalhe da pesquisa
1.
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study.
Lancet Oncol
; 24(10): 1119-1133, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37717583
2.
Use of bisphosphonates in multiple myeloma patients in Denmark, 2005-2015.
Support Care Cancer
; 29(8): 4501-4511, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33458807
3.
Nationwide implementation of lenalidomide maintenance in multiple myeloma: A retrospective, real-world study.
EJHaem
; 5(2): 316-324, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38633122
4.
Mitochondrial cytochrome c oxidase subunit II variations predict adverse prognosis in cytogenetically normal acute myeloid leukaemia.
Eur J Haematol
; 91(4): 295-303, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23826975
5.
Characterization and prognostic significance of mitochondrial DNA variations in acute myeloid leukemia.
Eur J Haematol
; 90(5): 385-96, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23444869
6.
[Monoclonal gammopathy of undetermined significance].
Ugeskr Laeger
; 182(10)2020 03 02.
Artigo
em Dinamarquês
| MEDLINE | ID: mdl-32138824
7.
The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML.
Eur J Haematol
; 83(5): 439-48, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19563517
8.
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.
Blood Cancer J
; 14(1): 65, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38622134
9.
Potential value of pre-planned imaging of bone disease in multiple myeloma.
Blood Cancer J
; 13(1): 105, 2023 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37419876
10.
Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio.
Blood Cancer J
; 11(4): 70, 2021 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33828079
11.
Multiplex PCR for the detection of BCL-1/IGH and BCL-2/IGH gene rearrangements--clinical validation in a prospective study of blood and bone marrow in 258 patients with or suspected of non-Hodgkin's lymphoma.
Acta Oncol
; 46(1): 21-30, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17438702